dc.creatorGübelin, Walter
dc.creatorMartínez, M. Angélica
dc.creatorMolina, M. Teresa
dc.creatorZapata, Solange
dc.creatorValenzuela, M. Eugenia
dc.date.accessioned2019-03-11T12:54:02Z
dc.date.available2019-03-11T12:54:02Z
dc.date.created2019-03-11T12:54:02Z
dc.date.issued2006
dc.identifierRevista Latinoamericana de Microbiologia, Volumen 48, Issue 1, 2018, Pages 14-16
dc.identifier01874640
dc.identifierhttps://repositorio.uchile.cl/handle/2250/164323
dc.description.abstractIn the last decade, a significant increase in the antimicrobial resistance of clinical specimens of Propionibacterium acnes to first line antibiotics used for acne treatment, has been informed in Europe and in the USA. No information about strains isolated from Latin-American countries is available. The antimicrobial susceptibility of 53 strains of P. acnes isolated from skin specimens of inflammatory acne patients, at the clinical Hospital University of Chile was tested. All isolates were susceptible to penicillin, minocycline, and nadifloxacin. Erythromycin and clindamycin resistance was found in 3.8 and 1.9% isolates respectively. Resistance to lymecycline was observed in one isolate, which was intermediate to tetracycline and doxycycline.
dc.languageen
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceRevista Latinoamericana de Microbiologia
dc.subjectAntimicrobial susceptibility
dc.subjectInflammatory acne
dc.subjectPropionibacterium acnes
dc.titleAntimicrobial susceptibility of strains of Propionibacterium acnes isolated from inflammatory acne
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución